Tag: Journal of Neuroimmune Pharmacology

Study: Cannabinoids are Safe, Effective for Pain Treatment

By Paul Armentano, NORML Cannabinoids are safe and effective for the treatment of chronic pain, according to the results of a systematic review of randomized controlled trials published in the Journal of Neuroimmune Pharmacology. Investigators from Dalhousie University in Halifax, Nova Scotia and McGill University in Montreal evaluated the results of 11 placebo-controlled trials conducted …

Continue reading

New Study: Cannabis May Treat Autoimmune Diseases, Prevent Graft Rejection

A new study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print by the National Institute of Health, has found that cannabis may have immunosuppressive and anti-inflammatory properties, which may help treat a variety of conditions such as autoimmune diseases and graft rejection. According to researchers; “This …

Continue reading

New Metastudy Finds Evidence that Cannabis is a Safe, Effective Treatment for Chronic Pain

A new metastudy of numerous randomized controlled trials has found that cannabis is a safe, effective treatment for chronic pain. The study was published in the Journal of Neuroimmune Pharmacology, and was published online Monday by the National Institute of Health. The study, conducted by researchers at Pharmacology Dalhousie University‘s Departments of Anesthesiology in Canada, …

Continue reading

Cannabis May Treat Neuroinflammation, According to New Study

A study published in the February issue of the Journal of NeuroImmune Pharmacology has found that cannabis may provide a treatment option for neuroinflammation. “Chronic neuroinflammatory disorders (such as HIV associated neurodegeneration) require treatment that decreases production of inflammatory factors by activated microglia and macrophages and protection of blood brain barrier (BBB) injury secondary to …

Continue reading

New Government-Funded Study: Cannabis May Treat HIV-Associated Neuro Cognitive Disorders

A study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print yesterday by the U.S. National Institute of Health (who also conducted the study), has found that cannabinoid agonists – such as cannabis – may attenuate HIV-associated neuro cognitive disorders in HIV patients on HAART (highly active antiretroviral therapy). …

Continue reading

New Study: Cannabis Can Treat Multiple Sclerosis By Preventing Inflammation

A new study published by the Journal of Neuroimmune Pharmacology has found that cannabis can treat multiple sclerosis by preventing inflammation in the brain and spinal cord. “Inflammation is part of the body’s natural immune response, but in cases like MS it gets out of hand,” says Drs. Ewa Kozela, co-author of the study. “Our …

Continue reading